Host Dr. Charles Turck talks with Dr. Karen Weiss, project lead for the FDA's Safe Use Initiative, and Dr. Dale Slavin, senior policy analyst. How is the FDA working to ensure that medications are used optimally once they’re available to the public? This program explains this collaborative initiative to address various types of preventable harm from medications.
The FDA's Safe Use Initiative
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Host Dr. Charles Turck talks with Dr. Karen Weiss, project lead for the FDA's Safe Use Initiative, and Dr. Dale Slavin, senior policy analyst. How is the FDA working to ensure that medications are used optimally once they’re available to the public? This program explains this collaborative initiative to address various types of preventable harm from medications.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Implementing the AMA MAPTM Hypertension Program: A Clinician’s Experience
Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
Novel Transcatheter Solution Approved for Tricuspid Regurgitation
Advancing Cardiology and Heart Surgery Through a History of Collaboration
Breakthroughs in Alopecia Areata Treatment
DWTV Extra: Culturally Conscious Dermatology
Emrosi Launched in the US for Rosacea
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?